DOD-CDMRP: Tuberous Sclerosis Complex Research Program (TSCRP) - Pre-proposal

- Clinical Trial Award: Fund Phase 0, I, or II clinical trials relevant to TSC. Combinations of phases are ermitted. Preliminary data required. Phase I or pilot clinical trial data required for Phase II clinical trial applications. Funding: max $1M over max 4 years.
- Exploration - Hypothesis Development Award: Fund the initial exploration of innovative, untested research and pursue serendipitous observations. Preliminary data is encouraged but not required. Projects involving human subjects or human anatomical substances must be exempt under 32 CFR 219.101(b) or eligible for expedited review under 32 CFR 219.110 or 21 CFR 56.110. Clinical trials are not allowed. Funding: max $100K over max 2 years.
- Idea Development Award: Encourage high impact, innovative research that will drive the field of TSC research forward. Preliminary data required. Optional Features: Applications that include either a Qualified Collaborator or Postdoctoral Fellow who meet criteria identified in the Program Announcement/Funding Opportunity may apply for a higher level of funding. Clinical trials not allowed. Funding: max $425K ($575K if requesting an Optional Qualified Collaborator or Postdoctoral Fellow).
https://cdmrp.org/Program_Announcements_and_Forms/